The European Heart Rhythm Association announces four late-breaking sessions of featured clinical science to be presented during their next annual congress.

EHRA 2025 will take place from 30th March to 1st April at Messe Wien in Vienna. Access the full programme here.

Late-Breaking Science: Cardiac Implantable Electrical Devices

Sunday 30th March, 13:45 – 14:45pm

• MORE-CRT MPP – Presented by Prof Christophe Leclercq
• Long-term outcomes of LBBP and BiVP in the treatment of chronic systolic heart failure with left bundle branch block: a multicenter, prospective, randomized, controlled trial – Presented by Dr Xueying Chen
• Device-related complications in patients with subcutaneous or transvenous defibrillator therapy during long-term follow-up: the primary results of the PRAETORIAN-XL trial
• Subcutaneous implantable defibrillator therapy in patients with brugada syndrome: data from a large multicentre registry – Presented by Dr Xueying Chen

Late-Breaking Science: Atrial Fibrillation Ablation

Monday 31st March, 13:15 – 14:15pm

• High power short duration radiofrequency ablation or cryoballoon ablation for paroxysmal atrial fibrillation – Presented by Dr Arian Sultan
• Pulsed field ablation or cryoballoon ablation for paroxysmal atrial fibrillation - the SINGLE SHOT CHAMPION randomized clinical trial – Presented by Prof Tobias Reichlin
• Volt CE mark study – Presented by Prof Roland Tilz
• Safety, effectiveness, and healthcare benefits of a dual energy focal ablation technology to treat paroxysmal atrial fibrillation: SmartfIRE 12-month results – Presented by Dr Tom De Potter

Late-Breaking Science: Clinical / Stroke

Tuesday 1st April, 08:30 – 09:30am

• Worldwide incidence, management and outcome of systemic embolism following atrial fibrillation ablation: preliminary results from the EMBOL-AF registry – Presented by Dr Sergio Castrejon
• 3-Year outcomes from the comparison of amulet and watchman/FLX device in patients undergoing left atrial appendage closure: the SWISS-APERO randomized clinical trial – Presented by Dr Roberto Galea
• DeteCtiON and Stroke PreventIon by MoDEl ScRreenING for Atrial Fibrillation – Presented by Dr Emma Sandgren
• Long-term outcomes of patients requiring pacemaker implantation after transcatheter aortic valve implantation: insights from the nationwide SwissTAVI registry – Presented by Prof Patrick Badertscher

Late-Breaking Science: Ventricular Tachycardia Present and Future

Tuesday 1st April, 10:45 – 11:45am

• Characterizing malignant arrhythmias in patients with arrhythmic mitral valve prolapse insights from the SAFE MVP collaboration – Presented by Dr Avi Sabbag
• Safety results from the european Affera Ventricular Arrhythmia Ablation Registry – Presented by Dr Frederic Sacher
• Future LBS - Clinical and arrhythmic outcomes of high-risk patients undergoing left ventricular assist device implant with intra-operative ventricular ablation: interim results from the PIVATAL trial – Presented by Dr David Huang
• Future LBS - Preventive catheter ablation for ventricular arrhythmias in patients with end-stage heart failure referred for heart transplantation evaluation – Presented by Prof Christian Sohns

References

EHRA Congress 2025. Scientific Programme. 2025. https://www.escardio.org/Congresses-Events/EHRA-Congress/Scientific-sessions (accessed 19 February 2025).